Table of Content
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF GLOBAL ULTRASOUND PROBE MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATION
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 KEY TAKEAWAYS
2.2 ARRIVING AT THE GLOBAL ULTRASOUND PROBE SIZE
2.2.1 VENDOR POSITIONING GRID
2.2.2 TECHNOLOGY LIFE LINE CURVE
2.2.3 TRIPOD DATA VALIDATION MODEL
2.2.4 MARKET GUIDE
2.2.5 MULTIVARIATE MODELLING
2.2.6 TOP TO BOTTOM ANALYSIS
2.2.7 CHALLENGE MATRIX
2.2.8 APPLICATION COVERAGE GRID
2.2.9 STANDARDS OF MEASUREMENT
2.2.10 VENDOR SHARE ANALYSIS
2.2.11 DATA POINTS FROM KEY PRIMARY INTERVIEWS
2.2.12 DATA POINTS FROM KEY SECONDARY DATABASES
2.3 GLOBAL ULTRASOUND PROBE MARKET: RESEARCH SNAPSHOT
2.4 ASSUMPTIONS
3 MARKET OVERVIEW
3.1 DRIVERS
3.2 RESTRAINTS
3.3 OPPORTUNITIES
3.4 CHALLENGES
4 EXECUTIVE SUMMARY
5 PREMIUM INSIGHTS
5.1 PESTEL ANALYSIS
5.2 PORTER’S FIVE FORCES MODEL
6 INDUSTRY INSIGHTS
6.1 MICRO AND MACRO ECONOMIC FACTORS
6.2 PENETRATION AND GROWTH PROSPECT MAPPING
6.3 KEY PRICING STRATEGIES
6.4 INTERVIEWS WITH SPECIALIST
6.5 ANALYIS AND RECOMMENDATION
7 INTELLECTUAL PROPERTY (IP) PORTFOLIO
7.1 PATENT QUALITY AND STRENGTH
7.2 PATENT FAMILIES
7.3 LICENSING AND COLLABORATIONS
7.4 COMPETITIVE LANDSCAPE
7.5 IP STRATEGY AND MANAGEMENT
7.6 OTHER
8 COST ANALYSIS BREAKDOWN
9 TECHNONLOGY ROADMAP
10 INNOVATION TRACKER AND STRATEGIC ANALYSIS
10.1 MAJOR DEALS AND STRATEGIC ALLIANCES ANALYSIS
10.1.1 JOINT VENTURES
10.1.2 MERGERS AND ACQUISITIONS
10.1.3 LICENSING AND PARTNERSHIP
10.1.4 TECHNOLOGY COLLABORATIONS
10.1.5 STRATEGIC DIVESTMENTS
10.2 NUMBER OF PRODUCTS IN DEVELOPMENT
10.3 STAGE OF DEVELOPMENT
10.4 TIMELINES AND MILESTONES
10.5 INNOVATION STRATEGIES AND METHODOLOGIES
10.6 RISK ASSESSMENT AND MITIGATION
10.7 FUTURE OUTLOOK
11 REGULATORY COMPLIANCE
11.1 REGULATORY AUTHORITIES
11.2 REGULATORY CLASSIFICATIONS
11.2.1 CLASS I
11.2.2 CLASS II
11.2.3 CLASS III
11.3 REGULATORY SUBMISSIONS
11.4 INTERNATIONAL HARMONIZATION
11.5 COMPLIANCE AND QUALITY MANAGEMENT SYSTEMS
11.6 REGULATORY CHALLENGES AND STRATEGIES
12 REIMBURSEMENT FRAMEWORK
13 OPPUTUNITY MAP ANALYSIS
14 VALUE CHAIN ANALYSIS
15 HEALTHCARE ECONOMY
15.1 HEALTHCARE EXPENDITURE
15.2 CAPITAL EXPENDITURE
15.3 CAPEX TRENDS
15.4 CAPEX ALLOCATION
15.5 FUNDING SOURCES
15.6 INDUSTRY BENCHMARKS
15.7 GDP RATION IN OVERALL GDP
15.8 HEALTHCARE SYSTEM STRUCTURE
15.9 GOVERNMENT POLICIES
15.1 ECONOMIC DEVELOPMENT
16 GLOBAL ULTRASOUND PROBE MARKET, BY TYPE
16.1 OVERVIEW
16.2 CONVEX PROBES
16.2.1 BY FREQUENCY
16.2.1.1. 1.0-5.0 MHZ
16.2.1.2. 2.0-6.0 MHZ
16.2.1.3. OTHERS
16.2.2 BY DESIGN
16.2.2.1. CURVED
16.2.2.2. LINEAR
16.2.3 BY BIOPSY GUIDE
16.2.3.1. MULTI-ANGLE
16.2.3.1.1. REUSBALE
16.2.3.1.2. DISPOSABLE
16.2.3.2. SINGLE-ANGLE
16.2.3.2.1. REUSABLE
16.2.3.2.2. DISPOSABLE
16.3 LINEAR PROBES
16.3.1 BY FREQUENCY
16.3.1.1. 7.5 MHZ
16.3.1.2. 14 MHZ
16.3.2 BY DESIGN
16.3.2.1. CURVED
16.3.2.2. LINEAR
16.4 PHASED-ARRAY
16.4.1 BY FREQUENCY
16.4.1.1. 2.7 MHZ
16.4.1.2. 4.5 MHZ
16.4.1.3. OTHERS
16.4.2 BY DESIGN
16.4.2.1. CURVED
16.4.2.2. LINEAR
16.5 PENCIL PROBES
16.5.1 BY FREQUENCY
16.5.1.1. 2.0 MHZ
16.5.1.2. 5.0 MHZ
16.5.1.3. 8.0 MHZ
16.5.1.4. OTHERS
16.6 ENDOCAVITARY PROBES
16.6.1 BY FREQUENCY
16.6.1.1. 6.0 MHZ
16.6.1.2. 7.0 MHZ
16.6.1.3. OTHERS
16.6.2 BY DESIGN
16.6.2.1. CURVED
16.6.2.2. LINEAR
16.7 MICROCONVEX-ARRAY PROBES
16.7.1 BY FREQUENCY
16.7.1.1. 3.5 MHZ
16.7.1.2. 6.5 MHZ
16.7.1.3. OTHERS
16.7.2 BY DESIGN
16.7.2.1. CURVED
16.7.2.2. LINEAR
16.8 TRANSESOPHAGEAL (TEE) PROBE
16.8.1 BY FREQUENCY
16.8.1.1. 5.0 MHZ
16.8.1.2. OTHERS
16.8.2 BY DESIGN
16.8.2.1. CURVED
16.8.2.2. LINEAR
16.9 BI-PLANE PROBES
16.9.1 BY FREQUENCY
16.9.1.1. 6.5 MHZ
16.9.1.2. 7 MHZ
16.9.1.3. OTHERS
16.9.2 BY DESIGN
16.9.2.1. CURVED
16.9.2.2. LINEAR
16.1 VOLUME PROBE
16.10.1 BY FREQUNCY
16.10.1.1. 3.75 MHZ
16.10.1.2. 3.8 MHZ
16.10.1.3. OTHERS
16.10.2 BY DESIGN
16.10.2.1. CURVED
16.10.2.2. LINEAR
16.11 LAPAROSCOPY PROBE
16.11.1 BY FREQUENCY
16.11.1.1. 7.0 MHZ
16.11.1.2. OTHERS
16.11.2 BY DESIGN
16.11.2.1. CURVED
16.11.2.2. LINEAR
16.12 INTRAOPERATIVE PROBE
16.12.1 BY FREQUENCY
16.12.1.1. 6.0 MHZ
16.12.1.2. 7.5 MHZ
16.12.1.3. OTHERS
16.12.2 BY DESIGN
16.12.2.1. CURVED
16.12.2.2. LINEAR
16.13 OTHERS
17 GLOBAL ULTRASOUND PROBE MARKET, BY FIELD OF VIEW
17.1 OVERVIEW
17.2 25 MM
17.3 38 MM
17.4 44 MM
17.5 OTHERS
18 GLOBAL ULTRASOUND ULTRASOUND PROBE MARKET, BY CONNECTIVITY
18.1 OVERVIEW
18.2 WIRELESS ULTRASOUND PROBE
18.3 WIRED UNTRASOUND PROBE
19 GLOBAL ULTRASOUND PROBE MARKET, BY APPLICATIONS
19.1 OVERVIEW
19.2 GASTROINTESTIAL TRACT
19.2.1 CONVEX PROBES
19.2.2 LINEAR PROBES
19.2.3 PHASED ARRAY PROBES
19.2.4 PENCIL TRNASDUCERS
19.2.5 ENDOCAVITARY PROBES
19.2.6 MICROCONVEX-ARRAY PROBES
19.2.7 TRANSESOPHAGEAL (TEE) PROBE
19.2.8 BI-LANE PROBES
19.2.9 VOLUME PROBES
19.2.10 LAPAROSCOPY PROBES
19.2.11 INTRAOPERATIVE PROBES
19.2.12 OTHERS
19.3 CARDIOLOGY
19.3.1 CONVEX PROBES
19.3.2 LINEAR PROBES
19.3.3 PHASED ARRAY PROBES
19.3.4 PENCIL TRNASDUCERS
19.3.5 ENDOCAVITARY PROBES
19.3.6 MICROCONVEX-ARRAY PROBES
19.3.7 TRANSESOPHAGEAL (TEE) PROBE
19.3.8 BI-LANE PROBES
19.3.9 VOLUME PROBES
19.3.10 LAPAROSCOPY PROBES
19.3.11 INTRAOPERATIVE PROBES
19.3.12 OTHERS
19.4 UROLOGY
19.4.1 CONVEX PROBES
19.4.2 LINEAR PROBES
19.4.3 PHASED ARRAY PROBES
19.4.4 PENCIL TRNASDUCERS
19.4.5 ENDOCAVITARY PROBES
19.4.6 MICROCONVEX-ARRAY PROBES
19.4.7 TRANSESOPHAGEAL (TEE) PROBE
19.4.8 BI-LANE PROBES
19.4.9 VOLUME PROBES
19.4.10 LAPAROSCOPY PROBES
19.4.11 INTRAOPERATIVE PROBES
19.4.12 OTHERS
19.5 OBSTETRICAL/GYNECOLOGICAL
19.5.1 CONVEX PROBES
19.5.2 LINEAR PROBES
19.5.3 PHASED ARRAY PROBES
19.5.4 PENCIL TRNASDUCERS
19.5.5 ENDOCAVITARY PROBES
19.5.6 MICROCONVEX-ARRAY PROBES
19.5.7 TRANSESOPHAGEAL (TEE) PROBE
19.5.8 BI-LANE PROBES
19.5.9 VOLUME PROBES
19.5.10 LAPAROSCOPY PROBES
19.5.11 INTRAOPERATIVE PROBES
19.5.12 OTHERS
19.6 ORTHOPEDIC AND MUSCULOSKELETAL
19.6.1 CONVEX PROBES
19.6.2 LINEAR PROBES
19.6.3 PHASED ARRAY PROBES
19.6.4 PENCIL TRNASDUCERS
19.6.5 ENDOCAVITARY PROBES
19.6.6 MICROCONVEX-ARRAY PROBES
19.6.7 TRANSESOPHAGEAL (TEE) PROBE
19.6.8 BI-LANE PROBES
19.6.9 VOLUME PROBES
19.6.10 LAPAROSCOPY PROBES
19.6.11 INTRAOPERATIVE PROBES
19.6.12 OTHERS
19.7 CRANIAL/NEUROLOGIC
19.7.1 CONVEX PROBES
19.7.2 LINEAR PROBES
19.7.3 PHASED ARRAY PROBES
19.7.4 PENCIL TRNASDUCERS
19.7.5 ENDOCAVITARY PROBES
19.7.6 MICROCONVEX-ARRAY PROBES
19.7.7 TRANSESOPHAGEAL (TEE) PROBE
19.7.8 BI-LANE PROBES
19.7.9 VOLUME PROBES
19.7.10 LAPAROSCOPY PROBES
19.7.11 INTRAOPERATIVE PROBES
19.7.12 OTHERS
19.8 OPHTHALMOLOGY
19.8.1 CONVEX PROBES
19.8.2 LINEAR PROBES
19.8.3 PHASED ARRAY PROBES
19.8.4 PENCIL TRNASDUCERS
19.8.5 ENDOCAVITARY PROBES
19.8.6 MICROCONVEX-ARRAY PROBES
19.8.7 TRANSESOPHAGEAL (TEE) PROBE
19.8.8 BI-LANE PROBES
19.8.9 VOLUME PROBES
19.8.10 LAPAROSCOPY PROBES
19.8.11 INTRAOPERATIVE PROBES
19.8.12 OTHERS
19.9 NEONATAL
19.9.1 CONVEX PROBES
19.9.2 LINEAR PROBES
19.9.3 PHASED ARRAY PROBES
19.9.4 PENCIL TRNASDUCERS
19.9.5 ENDOCAVITARY PROBES
19.9.6 MICROCONVEX-ARRAY PROBES
19.9.7 TRANSESOPHAGEAL (TEE) PROBE
19.9.8 BI-LANE PROBES
19.9.9 VOLUME PROBES
19.9.10 LAPAROSCOPY PROBES
19.9.11 INTRAOPERATIVE PROBES
19.9.12 OTHERS
19.1 OTHERS
20 GLOBAL ULTRASOUND PROBE MARKET, BY END USER
20.1 OVERVIEW
20.2 HOSPITALS
20.2.1 PUBLIC
20.2.2 PRIVATE
20.3 DIAGNOSTIC IMAGING CENTERS
20.4 AMBULATORY CARE CENTERS
20.5 MATERNITY CENTERS
20.6 CARDIAC CENTERS
20.7 ACADEMIC & RESEARCH INSTITUTES
20.8 OTHERS
21 GLOBAL ULTRASOUND PROBE MARKET, BY DISTRIBUTION CHANNEL
21.1 OVERVIEW
21.2 DIRECT TENDER
21.3 RETAIL SALES
21.4 OTHERS
22 GLOBAL ULTRASOUND PROBE MARKET, SWOT AND DBMR ANALYSIS
23 GLOBAL ULTRASOUND PROBE MARKET, COMPANY LANDSCAPE
23.1 COMPANY SHARE ANALYSIS: GLOBAL
23.2 COMPANY SHARE ANALYSIS: NORTH AMERICA
23.3 COMPANY SHARE ANALYSIS: EUROPE
23.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC
23.5 MERGERS & ACQUISITIONS
23.6 NEW PRODUCT DEVELOPMENT & APPROVALS
23.7 EXPANSIONS
23.8 REGULATORY CHANGES
23.9 PARTNERSHIP AND OTHER STRATEGIC DEVELOPMENTS
24 GLOBAL ULTRASOUND PROBE MARKET, BY REGION
GLOBAL ULTRASOUND PROBE MARKET, (ALL SEGMENTATION PROVIDED ABOVE IS REPRESENTED IN THIS CHAPTER BY COUNTRY)
24.1 NORTH AMERICA
24.1.1 U.S.
24.1.2 CANADA
24.1.3 MEXICO
24.2 EUROPE
24.2.1 GERMANY
24.2.2 U.K.
24.2.3 ITALY
24.2.4 FRANCE
24.2.5 SPAIN
24.2.6 RUSSIA
24.2.7 SWITZERLAND
24.2.8 TURKEY
24.2.9 BELGIUM
24.2.10 NETHERLANDS
24.2.11 DENMARK
24.2.12 SWEDEN
24.2.13 POLAND
24.2.14 NORWAY
24.2.15 FINLAND
24.2.16 REST OF EUROPE
24.3 ASIA-PACIFIC
24.3.1 JAPAN
24.3.2 CHINA
24.3.3 SOUTH KOREA
24.3.4 INDIA
24.3.5 SINGAPORE
24.3.6 THAILAND
24.3.7 INDONESIA
24.3.8 MALAYSIA
24.3.9 PHILIPPINES
24.3.10 AUSTRALIA
24.3.11 NEW ZEALAND
24.3.12 VIETNAM
24.3.13 TAIWAN
24.3.14 REST OF ASIA-PACIFIC
24.4 SOUTH AMERICA
24.4.1 BRAZIL
24.4.2 ARGENTINA
24.4.3 REST OF SOUTH AMERICA
24.5 MIDDLE EAST AND AFRICA
24.5.1 SOUTH AFRICA
24.5.2 EGYPT
24.5.3 BAHRAIN
24.5.4 UNITED ARAB EMIRATES
24.5.5 KUWAIT
24.5.6 OMAN
24.5.7 QATAR
24.5.8 SAUDI ARABIA
24.5.9 REST OF MEA
24.6 KEY PRIMARY INSIGHTS: BY MAJOR COUNTRIES
25 GLOBAL ULTRASOUND PROBE MARKET, COMPANY PROFILE
25.1 GE HEALTHCARE
25.1.1 COMPANY OVERVIEW
25.1.2 REVENUE ANALYSIS
25.1.3 GEOGRAPHIC PRESENCE
25.1.4 PRODUCT PORTFOLIO
25.1.5 RECENT DEVELOPMENTS
25.2 BEIJING KONTED MEDICAL TECHNOLOGY CO.,LTD.
25.2.1 COMPANY OVERVIEW
25.2.2 REVENUE ANALYSIS
25.2.3 GEOGRAPHIC PRESENCE
25.2.4 PRODUCT PORTFOLIO
25.2.5 RECENT DEVELOPMENTS
25.3 SIEMENS HEALTHCARE PRIVATE LIMITED
25.3.1 COMPANY OVERVIEW
25.3.2 REVENUE ANALYSIS
25.3.3 GEOGRAPHIC PRESENCE
25.3.4 PRODUCT PORTFOLIO
25.3.5 RECENT DEVELOPMENTS
25.4 AMD GLOBAL TELEMEDICINE
25.4.1 COMPANY OVERVIEW
25.4.2 REVENUE ANALYSIS
25.4.3 GEOGRAPHIC PRESENCE
25.4.4 PRODUCT PORTFOLIO
25.4.5 RECENT DEVELOPMENTS
25.5 OLYMPUS CORPORATION
25.5.1 COMPANY OVERVIEW
25.5.2 REVENUE ANALYSIS
25.5.3 GEOGRAPHIC PRESENCE
25.5.4 PRODUCT PORTFOLIO
25.5.5 RECENT DEVELOPMENTS
25.6 BK MEDICAL HOLDING COMPANY, INC.
25.6.1 COMPANY OVERVIEW
25.6.2 REVENUE ANALYSIS
25.6.3 GEOGRAPHIC PRESENCE
25.6.4 PRODUCT PORTFOLIO
25.6.5 RECENT DEVELOPMENTS
25.7 SAMSUNG
25.7.1 COMPANY OVERVIEW
25.7.2 REVENUE ANALYSIS
25.7.3 GEOGRAPHIC PRESENCE
25.7.4 PRODUCT PORTFOLIO
25.7.5 RECENT DEVELOPMENTS
25.8 ESAOTE SPA
25.8.1 COMPANY OVERVIEW
25.8.2 REVENUE ANALYSIS
25.8.3 GEOGRAPHIC PRESENCE
25.8.4 PRODUCT PORTFOLIO
25.8.5 RECENT DEVELOPMENTS
25.9 GOBALMED
25.9.1 COMPANY OVERVIEW
25.9.2 REVENUE ANALYSIS
25.9.3 GEOGRAPHIC PRESENCE
25.9.4 PRODUCT PORTFOLIO
25.9.5 RECENT DEVELOPMENTS
25.1 SHENZHEN WELLD MEDICAL ELECTRONICS CO., LTD.
25.10.1 COMPANY OVERVIEW
25.10.2 REVENUE ANALYSIS
25.10.3 GEOGRAPHIC PRESENCE
25.10.4 PRODUCT PORTFOLIO
25.10.5 RECENT DEVELOPMENTS
25.11 FUJIFILLM
25.11.1 COMPANY OVERVIEW
25.11.2 REVENUE ANALYSIS
25.11.3 GEOGRAPHIC PRESENCE
25.11.4 PRODUCT PORTFOLIO
25.11.5 RECENT DEVELOPMENTS
25.12 MIANYANG ULTRASOUND XIANFENG COMPANY
25.12.1 COMPANY OVERVIEW
25.12.2 REVENUE ANALYSIS
25.12.3 GEOGRAPHIC PRESENCE
25.12.4 PRODUCT PORTFOLIO
25.12.5 RECENT DEVELOPMENTS
25.13 KONINKLIJKE PHILIPS N.V.
25.13.1 COMPANY OVERVIEW
25.13.2 REVENUE ANALYSIS
25.13.3 GEOGRAPHIC PRESENCE
25.13.4 PRODUCT PORTFOLIO
25.13.5 RECENT DEVELOPMENTS
25.14 HITACHI, LTD.
25.14.1 COMPANY OVERVIEW
25.14.2 REVENUE ANALYSIS
25.14.3 GEOGRAPHIC PRESENCE
25.14.4 PRODUCT PORTFOLIO
25.14.5 RECENT DEVELOPMENTS
25.15 MINDRAY LTD.
25.15.1 COMPANY OVERVIEW
25.15.2 REVENUE ANALYSIS
25.15.3 GEOGRAPHIC PRESENCE
25.15.4 PRODUCT PORTFOLIO
25.15.5 RECENT DEVELOPMENTS
25.16 SONOSCAPE MEDICAL CORP.
25.16.1 COMPANY OVERVIEW
25.16.2 REVENUE ANALYSIS
25.16.3 GEOGRAPHIC PRESENCE
25.16.4 PRODUCT PORTFOLIO
25.16.5 RECENT DEVELOPMENTS
25.17 NIHON DEMPA KOGYO CO., LTD.
25.17.1 COMPANY OVERVIEW
25.17.2 REVENUE ANALYSIS
25.17.3 GEOGRAPHIC PRESENCE
25.17.4 PRODUCT PORTFOLIO
25.17.5 RECENT DEVELOPMENTS
25.18 CANON MEDICAL SYSTEMS, INC.
25.18.1 COMPANY OVERVIEW
25.18.2 REVENUE ANALYSIS
25.18.3 GEOGRAPHIC PRESENCE
25.18.4 PRODUCT PORTFOLIO
25.18.5 RECENT DEVELOPMENTS
25.19 TERASON CORPORATION
25.19.1 COMPANY OVERVIEW
25.19.2 REVENUE ANALYSIS
25.19.3 GEOGRAPHIC PRESENCE
25.19.4 PRODUCT PORTFOLIO
25.19.5 RECENT DEVELOPMENTS
25.2 ALPINION MEDICAL SYSTEMS
25.20.1 COMPANY OVERVIEW
25.20.2 REVENUE ANALYSIS
25.20.3 GEOGRAPHIC PRESENCE
25.20.4 PRODUCT PORTFOLIO
25.20.5 RECENT DEVELOPMENTS
25.21 KOELIS
25.21.1 COMPANY OVERVIEW
25.21.2 REVENUE ANALYSIS
25.21.3 GEOGRAPHIC PRESENCE
25.21.4 PRODUCT PORTFOLIO
25.21.5 RECENT DEVELOPMENTS
25.22 MEDELCOM
25.22.1 COMPANY OVERVIEW
25.22.2 REVENUE ANALYSIS
25.22.3 GEOGRAPHIC PRESENCE
25.22.4 PRODUCT PORTFOLIO
25.22.5 RECENT DEVELOPMENTS
25.23 ANALOGIC CORPORATION
25.23.1 COMPANY OVERVIEW
25.23.2 REVENUE ANALYSIS
25.23.3 GEOGRAPHIC PRESENCE
25.23.4 PRODUCT PORTFOLIO
25.23.5 RECENT DEVELOPMENTS
25.24 TOSHIBA CORPORATION
25.24.1 COMPANY OVERVIEW
25.24.2 REVENUE ANALYSIS
25.24.3 GEOGRAPHIC PRESENCE
25.24.4 PRODUCT PORTFOLIO
25.24.5 RECENT DEVELOPMENTS
25.25 FUKUDA DENSHI
25.25.1 COMPANY OVERVIEW
25.25.2 REVENUE ANALYSIS
25.25.3 GEOGRAPHIC PRESENCE
25.25.4 PRODUCT PORTFOLIO
25.25.5 RECENT DEVELOPMENTS
26 RELATED REPORTS
27 CONCLUSION
28 QUESTIONNAIRE
29 ABOUT DATA BRIDGE MARKET RESEARCH
